Published in Medicine and Law Weekly, October 20th, 2006
Sigma was the defendant in a suit brought by Enzo alleging, among other things, breach of contract and infringement of patents related to the company's proprietary labeled nucleotide technology.
The settlement agreement followed the recent Markman Hearing ruling by a Federal Court Judge in the Southern District of New York relating to claim terms in eight patents asserted against Sigma. Terms of the settlement are confidential.
"Enzo is pleased to have settled with Sigma-Aldrich on favorable terms. Sigma is the first defendant to settle in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.